(Q34708892)

4 August 2017

1 reference

title

Gliclazide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in diabetes mellitus. (English)

1 reference

4 August 2017

1 reference

3

Brogden RN

1 reference

4 August 2017

Holmes B

1

1 reference

4 August 2017

Heel RC

series ordinal

2

1 reference

4 August 2017

Speight TM

series ordinal

4

1 reference

4 August 2017

Avery GS

series ordinal

5

1 reference

4 August 2017

1 April 1984

1 reference

4 August 2017

1 reference

4 August 2017

27

1 reference

4 August 2017

4

1 reference

4 August 2017

301-327

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-198427040-00002

4 August 2017

0 references

cites work

Effect of gliclazide on prostaglandin and thromboxane synthesis in guinea-pig platelets

1 reference

12 December 2020

[The real problem in diabetes (trial of gliclazide, an original molecule with metabolic and vascular properties)]

1 reference

12 December 2020

Effects of gliclazide and glibenclamide on platelet function, fibrinolysis and metabolic control in diabetic patients with retinopathy (author's transl)

1 reference

12 December 2020

Platelet Function and Diabetes Mellitus

1 reference

12 December 2020

Effect on platelet adhesiveness in diabetics after long-term treatment with a new oral hypoglycaemic agent, gliclazide

1 reference

12 December 2020

The effects of gliclazide on platelet function in patients with diabetes mellitus

1 reference

12 December 2020

Effect of prostacyclin (PGI2) on platelet adhesion to rabbit arterial subendothelium

1 reference

12 December 2020

Effects of the sulphonylurea drugs gliclazide and glibenclamide on blood glucose control and platelet function

1 reference

12 December 2020

[Effect of gliclazide on platelet behavior]

1 reference

12 December 2020

Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregation

1 reference

12 December 2020

[Clinical trial with a new oral antidiabetic, gliclazid, in general practice (author's transl)]

1 reference

12 December 2020

Sulphonylureas in vitro do not alter insulin binding or insulin effect on amino acid transport in rat hepatocytes

1 reference

12 December 2020

Effect of chlorpropamide and gliclazide on plasminogen activator activity in vascular walls in patients with maturity onset diabetes

1 reference

12 December 2020

[Gliclazide, a new antidiabetic with hemobiologic and vascular properties]

1 reference

12 December 2020

Long term improvement in insulin response with gliclazide treatment

1 reference

12 December 2020

Influence of blood proteins on biomedical analysis. III. Pharmacokinetics and protein binding of gliclazide

1 reference

12 December 2020

Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal

1 reference

12 December 2020

Inhibitory effect of gliclazide on platelet adhesiveness and aggregation in alloxan diabetic rabbits (author's transl)

1 reference

12 December 2020

Effect of gliclazide on prostaglandin I2 formation in normal and streptozotocin-induced diabetic animals

1 reference

12 December 2020

Interaction of miconazole and sulfamides with hypoglycemic action

1 reference

12 December 2020

Transport of Pr3+ by hypoglycemic sulfonylureas across liposomal membranes

1 reference

12 December 2020

Comparison of the in vitro effect of biguanides and sulfonylureas on insulin binding of its receptors in target cells

1 reference

12 December 2020

Anti-platelet effects of long-term treatment with gliclazide in diabetic patients

1 reference

12 December 2020

The pharmacology of S 1702, a new highly effective oral antibiabetic drug with unusual properties. 1. Pharmacological and hypoglycaemic activity, studies in different animal species.

1 reference

12 December 2020

Platelets and diabetes mellitus

1 reference

12 December 2020

The effects of gliclazide in diabetes: a comparison with tolbutamide

1 reference

12 December 2020

[Therapeutic value of a new original oral antidiabetic with vascular action: gliclazide (SE-1702)]

1 reference

12 December 2020

Effect of administration of hypoglycemic sulfonamide on glycoregulation balance

1 reference

12 December 2020

Inhibition and induction of microsomal enzymes in rat. A comparative study of four antimycotics: miconazole, econazole, clotrimazole and ketoconazole

1 reference

12 December 2020

[Medium term effect (3 months) of hypoglycemic sulfamide treatment (gliclazide) on insulin secretion of the non-insulin dependent diabetic]

1 reference

12 December 2020

[Drug interactions involving miconazole]

1 reference

12 December 2020

Effects of oral hypoglycemic agents, gliclazide and tolbutamide, on the cardiovascular system (author's transl)

1 reference

12 December 2020

The pharmacology S 1702, a new highly effective oral antidiabetic drug with unusual properties. 3. Antistickiness activity, fibrinolytic properties and haemostatic parameters study

1 reference

12 December 2020

An evaluation of the effects of some sulphonylureas on platelet function

1 reference

12 December 2020

Effects of diet and gliclazide on the haemostatic system of non-insulin-dependent diabetics.

1 reference

12 December 2020

Gliclazide (diamicron) in metabolic and vascular treatment of diabetes mellitus

1 reference

12 December 2020

[The "in vitro" effect of gliclazide, a new hypoglycemic agent, on normal human blood platelets]

1 reference

12 December 2020

10.2165/00003495-198427040-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

4 August 2017

0 references

1 reference